glp 1 off label use Off-Label' Dosing to Personalize GLP-1 Doses Trends in Off-Label Use from

Retrieved October 10, 2017

Published research on the individual peptides includes studies of: tendon biology ligament repair skeletal muscle connective tissue remodelling angiogense cicatrisation soft-tissue regeneration Because these research areas frequently overlap, combining BPC-157 and TB-500 into a single formulation has become a common approach in laboratory research

Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease

Thats why personalization matters

This means that it is stabilized via lyophilization, which ensures a longer shelf life and optimal stability during storage

If these claims pan out (and they seem to be doing so), we may be looking at a very versatile therapeutic peptide that can be used to treat diseases like inflammatory bowel disease, skin diseases, arthritis, asthma, and a variety of other inflammatory illnesses